𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Surgery for borderline tumor of the ovary

✍ Scribed by Claes G. Tropé; Gunnar Kristensen; Amin Makar

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
49 KB
Volume
19
Category
Article
ISSN
8756-0437

No coin nor oath required. For personal study only.

✦ Synopsis

The five-year survival for women with Stage I borderline tumors is about 95% to 97%, but because of late recurrence the 10-year survival is only 70% to 95%. The five-year survival for Stage II-III patients is 65% to 87%. A more correct staging procedure, classification of true serous implants, and agreement on how the presence of gelatinous ascites in mucinous tumors contributes to cancer stage might change the distribution of stage and survival data by stage for women with borderline tumors in the future. Independent prognostic factors for patients with borderline tumors without residual tumor after primary surgery are: DNA ploidy, morphometry, International Federation of Gynecology and Obstetrics (FIGO) stage, histologic type, and age. Different types of surgery and chemotherapy were not independent prognostic factors. Questions which should be addressed include the following: 1) Have patients with borderline tumors been over treated in general, and how should these patients be treated? 2) In which group of patients is fertility-sparing surgery advisable? 3) Do patients with borderline tumors benefit from adjuvant treatment? And 4) How is the high-risk patient defined?

📜 SIMILAR VOLUMES

Serous borderline tumors of the ovary wi
Serous borderline tumors of the ovary with noninvasive peritoneal implants
✍ David M. Gershenson; Elvio G. Silva; Guillermo Tortolero-Luna; Charles Levenback 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 2 views

## BACKGROUND. The authors conducted this study to update their experience with patients who have ovarian serous borderline tumors with noninvasive peritoneal implants, with the objectives of gaining additional insight into the biologic behavior of these tumors and understanding better the effects

Borderline tumors of the ovary : Fertili
Borderline tumors of the ovary : Fertility treatment, conservative management, and pregnancy outcome
✍ Walter H. Gotlieb; Sharon Flikker; Ben Davidson; Yaacov Korach; Juri Kopolovic; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 1 views

Seventeen patients did benefit from contralateral ovarian dissection Sackler School of Medicine, Sheba Medical Ceneither by cystectomy or oophorectomy because of contralateral benign or borderter, Tel Hashomer, Israel. line disease. Eleven patients had received or were scheduled to receive ovulation

The treatment for dysgerminoma of the ov
The treatment for dysgerminoma of the ovary
✍ Garry Krepart; Julian P. Smith; Felix Rutledge; Luis Delclos 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 390 KB 👁 1 views

Tumor Institute between 1947 and 1974. Twenty-six of these patients had their initial surgery at the M. D. Anderson Hospital or were referred to the M. D. Anderson Hospital shortly after surgery at another hospital. The remaining 10 were referred after developing a recurrence of their tumor. Five of

The current status of surgical staging o
The current status of surgical staging of ovarian serous borderline tumors
✍ Paul S. Lin; David M. Gershenson; Michael W. Bevers; Kristin R. Lucas; Thomas W. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## Background: The purpose of the current study was to evaluate the current practice of surgical staging of ovarian serous borderline tumors. ## Methods: Women with a diagnosis of ovarian serous borderline tumors whose pathology slides were sent to the m. d. anderson cancer center for second-opin

Prognostic factors in adult granulosa ce
Prognostic factors in adult granulosa cell tumor of the ovary
✍ Brigitte E. Miller; Beth A. Barron; Jim Y. Wan; James E. Delmore; Elvio G. Silva 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

## Background: The clinical course of adult granulosa cell tumor of the ovary is characterized by indolent growth tending toward late recurrence. a variety of clinical and pathologic parameters have previously been evaluated for prognostication with inconclusive results. ## Methods: The clinical